Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Nestlé recalls infant formula in 49 countries. See list. - 2Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
- 3One-third of asylum applications by Iranians approved in Germany
- 42025 among world's three hottest years on record, WMO says
- 52023's Best 10 Cell phone Advancements You Can't Miss
- Palestine weekly wrap: Protests sweep West Bank after death penalty law
- Home Remodel Administrations: Change Your Residing Space
- Understanding Preschool Projects: Cultivating Abilities and Advancement
- Only 30% of young people in Israel optimistic about future, Aluma survey reveals
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- There’s ‘super flu,’ COVID, RSV. Is it going around in SoCal?
- Australian State Triggers Emergency Powers Amid Fuel Crisis
- Unraveling the Specialty of Picking Your Ideal Travel Objective
- Spanish woman, 25, dies by legal euthanasia in case that drew national spotlight
